GSK is extending its relationship with the University of Oxford to research the potential of cancer prevention through vaccine-like immunotherapies.
GSK And Oxford To Collaborate On Neoantigen Vaccines To Prevent Cancer
The potentially groundbreaking approach would use immunotherapy or targeted therapies against pre-cancerous cells to prevent cancer from developing at all.
